// App-Quantinova.ai

SAT0345 : IS THERE A DIFFERENCE BETWEEN THE SEXES IN THE RATE OF PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD)? DATA FROM THE SENSCIS TRIAL

Researchers

Presenter

  • E. Volkmann

Principal Investigators

  • S. Vettori

  • J. Varga

  • A. Herrick

  • M. Cutolo

  • A. Cordeiro

  • V. F. Azevedo

  • S. Johnson

  • C. Stock

  • M. Gahlemann

  • L. Moros

  • M. Alves

  • M. Mayes

Medical Centers

  • Department of Medicine, Division of Rheumatology, University of California, David Geffen School of Medicine, Los Angeles, California, United States of America

  • Universita Della Campania "Luigi Vanvitelli", Napoli, Italy

  • Northwestern Scleroderma, Feinberg School of Medicine, Chicago, Illinois, United States of America

  • Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Genoa, Italy

  • Department of Paediatrics, Hospital Garcia de Orta, Almada, Portugal

  • Hospital de Clínicas, Federal University of Paraná, Curitiba, Paraná, Brazil

  • Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

  • Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany

  • Boehringer Ingelheim (Schweiz), GmbH, Basel, Switzerland,

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, Texas, USA, Houston, TX

Locations

  • United States

  • Italy

  • United Kingdom

  • Portugal

  • Brazil

  • Canada

  • Germany

  • Switzerland

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Formation Biologics Inc.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved